Creating a free account will enable you to subscribe to our daily and weekly email newsletters, as well as customize your reading experience to show only the categories most relevant to you.
Signing up only take a few minutes, so why not give it a try and see what you've been missing out on.
Huntington's disease (HD) is a hereditary disorder characterized by the progressive onset of neurodegeneration.
Children of HD patients have a 50% chance of inheriting the disease, but symptoms do not appear until middle age.
While genetic testing reliably determines if children of HD sufferers are carriers of the disease, it cannot provide information as to when symptoms will appear.
In this issue of the Journal of Clinical Investigation, David Eidelberg and colleagues at the Feinstein Institute of Medical Research, evaluated changes in the brain metabolism of a small group of preclinical HD carriers over the course of seven years and identified a metabolic network that is associated with HD progression. Measurable increases in the activity of this network were predictive of time to symptom onset.
This study provides biomarkers for evaluating disease progression in HD carriers and supports incorporating this assessment into clinical trials of HD treatment.
This study was funded by the NIH (National Institute of Neurological Disorders and Stroke, National Institute of Biomedical Imaging and Bioengineering) and CHDI Foundation Inc. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, etc.
J Clin Invest. doi:10.1172/JCI69411.
Article adapted by Medical News Today from original press release. Click 'references' tab above for source.
Visit our Huntingtons Disease category page for the latest news on this subject.
Please use one of the following formats to cite this article in your essay, paper or report:
Journal of Clinical Investigation. "Changes in brain metabolism enable tracking of Huntington's disease." Medical News Today. MediLexicon, Intl., 2 Sep. 2013. Web.
8 Dec. 2013. <http://www.medicalnewstoday.com/releases/265439>
Journal of Clinical Investigation. (2013, September 2). "Changes in brain metabolism enable tracking of Huntington's disease." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
If you write about specific medications, operations, or procedures please do not name healthcare professionals by name.
For any corrections of factual information, or to contact the our editorial team, please use our feedback form. Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
This page was printed from: http://www.medicalnewstoday.com/releases/265439.php
Visit www.medicalnewstoday.com for medical news and health news headlines posted throughout the day, every day.
© 2004-2013 All rights reserved. MNT (logo) is the registered trade mark of MediLexicon International Limited.